Aortic wall remodeling in rats with nitric oxide deficiency treated by enalapril or verapamil

Pathology Research and Practice

Volumn 200, Issue 3, 2004, Pages 211-217

  Pereira, Leila M M ^a   Bezerra, Daniele G ^a   Mandarim de Lacerda, Carlos A ^a  

^a STATE UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

Aorta; Enalapril; Nitric oxide; Stereology; Verapamil

Indexed keywords

ENALAPRIL; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; VERAPAMIL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA MEDIA; AORTA WALL; ARTICLE; BIOSYNTHESIS; BLOOD PRESSURE; BLOOD PRESSURE REGULATION; CARDIOVASCULAR PARAMETERS; CELL NUCLEUS; CONTROLLED STUDY; DENSITY; DRUG EFFICACY; DRUG MECHANISM; HEART LEFT VENTRICLE MASS; HEART VENTRICLE HYPERTROPHY; HYPERTROPHY; LAMELLAR BODY; MALE; NONHUMAN; RAT; RAT STRAIN; SMOOTH MUSCLE FIBER; SURFACE PROPERTY; THICKNESS; TISSUE SECTION; TUNICA MEDIA;

EID: 3242689060     PISSN: 03440338     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.prp.2003.12.008     Document Type: Article

References (45)

1. Aguila M.B. Mandarim-de-Lacerda C.A. Aorta wall quantitative alterations due to different long-term high-fat diet in rats Food Chem. Toxicol. 41 2003 1391-1397
2. Baddeley A.J. Gundersen H.J. Cruz-Orive L.M. Estimation of surface area from vertical sections J. Microsc. 142 Pt 3 1986 259-276
3. Bezie Y. Lamaziere J.M. Laurent S. Challande P. Cunha R.S. Bonnet J. Lacolley P. Fibronectin expression and aortic wall elastic modulus in spontaneously hypertensive rats Arterioscler. Thromb. Vasc. Biol. 18 1998 1027-1034
4. Buus C.L. Pourageaud F. Fazzi G.E. Janssen G. Mulvany M.J. De Mey J.G. Smooth muscle cell changes during flow-related remodeling of rat mesenteric resistance arteries Circ. Res. 89 2001 180-186
5. Carson F.L. Martin J.H. Lynn J.A. Formalin fixation for electron microscopy: a re-evaluation Am. J. Clin. Pathol. 59 1973 365-373
6. Chien S. Li S. Shyy Y.J. Effects of mechanical forces on signal transduction and gene expression in endothelial cells Hypertension 31 1998 162-169
7. Cooper A.L. Beasley D. Hypoxia stimulates proliferation and interleukin-1alpha production in human vascular smooth muscle cells Am. J. Physiol. 277 1999 H1326-H1337
8. Cruzado M. Castro C. Risler N. Miatello R. Changes of inducible nitric oxide synthase in aortic cells during the development of hypertension: effect of angiotensin II Biocell 26 2002 61-67
9. Devlin A.M. Brosnan M.J. Graham D. Morton J.J. McPhaden A.R. McIntyre M. Hamilton C.A. Reid J.L. Dominiczak A.F. Vascular smooth muscle cell polyploidy and cardiomyocyte hypertrophy due to chronic NOS inhibition in vivo Am. J. Physiol. 274 1998 H52-H59
10. Fitch R.M. Vergona R. Sullivan M.E. Wang Y.X. Nitric oxide synthase inhibition increases aortic stiffness measured by pulse wave velocity in rats Cardiovasc. Res. 51 2001 351-358
11. Folkow B. Hallback M. Lundgren Y. Sivertsson R. Weiss L. Importance of adaptive changes in vascular design for establishment of primary hypertension, studied in man and in spontaneously hypertensive rats Circ. Res. 32 Suppl 1 1973 2-16
12. Garg U.C. Hassid A. Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells J. Clin. Invest. 83 1989 1774-1777
13. Holecyova A. Torok J. Bernatova I. Pechanova O. Restriction of nitric oxide rather than elevated blood pressure is responsible for alterations of vascular responses in nitric oxide-deficient hypertension Physiol. Res. 45 1996 317-321
14. Hu Y. Bock G. Wick G. Xu Q. Activation of PDGF receptor alpha in vascular smooth muscle cells by mechanical stress FASEB J. 12 1998 1135-1142
15. Humphrey J.D. Wilson E. A potential role of smooth muscle tone in early hypertension: a theoretical study J. Biomech. 36 2003 1595-1601
16. Karam H. Heudes D. Bruneval P. Gonzales M.F. Loffler B.M. Clozel M. Clozel J.P. Endothelin antagonism in end-organ damage of spontaneously hypertensive rats. Comparison with angiotensin-converting enzyme inhibition and calcium antagonism Hypertension 28 1996 379-385
17. Koffi I. Safar M.E. Labat C. Lacolley P. Benetos A. Mourad J.J. Arterial structural changes with verapamil in spontaneously hypertensive rats Am. J. Hypertens. 12 1999 732-738
18. Kolpakov V. Gordon D. Kulik T.J. Nitric oxide-generating compounds inhibit total protein and collagen synthesis in cultured vascular smooth muscle cells Circ. Res. 76 1995 305-309
19. Mandarim-de-Lacerda C.A. What is the interest of normal and pathological morphological research to be quantitative? The example of the stereology Braz. J. Morphol. Sci. 16 1999 131-139
20. Mandarim-de-Lacerda C.A. Pereira L.M. Heart biometry and allometry in rats submitted to nitric oxide synthesis blockade and treatment with antihypertensive drugs Ann. Anat. 183 2001 171-176
21. Mandarim-de-Lacerda C.A. Pereira L.M. Renal cortical remodelling by NO-synthesis blockers in rats is prevented by angiotensin-converting enzyme inhibitor and calcium channel blocker J. Cell Mol. Med. 5 2001 276-283
22. Mandarim-de-Lacerda C.A. Pereira L.M. Volume-weighted mean nuclear volume and numerical nuclear density in the cardiomyocyte following enalapril and verapamil treatment Virchows Arch. 438 2001 92-95
23. Mathieu-Costello O. Fronek K. Morphometry of the amount of smooth muscle cells in the media of various rabbit arteries J. Ultrastruct. Res. 91 1985 1-12
24. Matsumoto T. Hayashi K. Stress and strain distribution in hypertensive and normotensive rat aorta considering residual strain J. Biomech. Eng. 118 1996 62-73
25. Mazzadi A. Gomez Llambi H. Basso N. Effect of enalapril treatment on the heart of normal rats Clin. Exp. Hypertens. 20 1998 867-884
26. McGuffee L.J. Little S.A. Tunica media remodeling in mesenteric arteries of hypertensive rats Anat. Rec. 246 1996 279-292
27. McNamara D.B. Bedi B. Aurora H. Tena L. Ignarro L.J. Kadowitz P.J. Akers D.L. L-arginine inhibits balloon catheter-induced intimal hyperplasia Biochem. Biophys. Res. Commun. 193 1993 291-296
28. Moreno H.Jr. Metze K. Bento A.C. Antunes E. Zatz R. de Nucci G. Chronic nitric oxide inhibition as a model of hypertensive heart muscle disease Basic Res. Cardiol. 91 1996 248-255
29. Mulvany M.J. Aalkjaer C. Structure and function of small arteries Physiol. Rev. 70 1990 921-961
30. Numaguchi K. Egashira K. Takemoto M. Kadokami T. Shimokawa H. Sueishi K. Takeshita A. Chronic inhibition of nitric oxide synthesis causes coronary microvascular remodeling in rats Hypertension 26 1995 957-962
31. Oliveira C.F. Cintra K.A. Teixeira S.A. De Luca I.M. Antunes E. De Nucci G. Development of cardiomyocyte hypotrophy in rats under prolonged treatment with a low dose of a nitric oxide synthesis inhibitor Eur. J. Pharmacol. 391 2000 121-126
32. Pereira L.M. Mandarim-de-Lacerda C.A. Quantitative examination of the cardiac myocytes in hypertensive rats under chronic inhibition of nitric oxide synthesis J. Biomed. Sci. 5 1998 363-369
33. Pereira L.M. Mandarim-de-Lacerda C.A. The effect of enalapril and verapamil on the left ventricular hypertrophy and the left ventricular cardiomyocyte numerical density in rats submitted to nitric oxide inhibition Int. J. Exp. Pathol. 82 2001 115-122
34. Pereira L.M. Mandarim-de-Lacerda C.A. Stereology of cardiac hypertrophy induced by NO blockade in rats treated with enalapril and verapamil Anal. Quant. Cytol. Histol. 23 2001 330-338
35. Pereira L.M. Vianna G.M. Mandarim-de-Lacerda C.A. Stereology of the myocardium in hypertensive rats. Differences in relation to the time of inhibition of nitric oxide synthesis Virchows Arch. 433 1998 369-373
36. Puscas I. Gilau L. Coltau M. Pasca R. Domuta G. Baican M. Hecht A. Calcium channel blockers reduce blood pressure in part by inhibiting vascular smooth muscle carbonic anhydrase I Cardiovasc. Drugs Therapy 14 2000 523-528
37. Safar M.E. Frohlich E.D. The arterial system in hypertension. A prospective view Hypertension 26 1995 10-14
38. Schiffrin E.L. Effects of antihypertensive drugs on vascular remodeling: do they predict outcome in response to antihypertensive therapy? Curr. Opin. Nephrol. Hypertens 10 2001 617-624
39. Svendsen E. Tindall A.R. The circumferential length of the internal elastic membrane measured by computer digitizer morphometry, and its relation to in vivo aorta diameter Acta Anat. 117 1983 145-151
40. Tang J. Zhou Q. Wu C. Liang Q. Effects of perindopril on vascular wall and left ventricular hypertrophy in rats with experimental hypertension J. Tongji Med. Univ. 18 1998 78-82
41. Ueno H. Kanellakis P. Agrotis A. Bobik A. Blood flow regulates the development of vascular hypertrophy, smooth muscle cell proliferation, and endothelial cell nitric oxide synthase in hypertension Hypertension 36 2000 89-96
42. Wilmink A.B. Vardulaki K.A. Hubbard C.S. Day N.E. Ashton H.A. Scott A.P. Quick C.R. Are antihypertensive drugs associated with abdominal aortic aneurysms? J. Vasc. Surg. 36 2002 751-757
43. Xu C. Lee S. Singh T.M. Sho E. Li X. Sho M. Masuda H. Zarins C.K. Molecular mechanisms of aortic wall remodeling in response to hypertension J. Vasc. Surg. 33 2001 570-578
44. J.H. Zar, Biostatistical analysis, Prentice-Hall, Upper Saddle River, Englewood Cliffs, NJ, 1999 p. 663
45. Zhao H. Shimokawa H. Uragami-Harasawa L. Igarashi H. Takeshita A. Long-term vascular effects of Nomega-nitro-L-arginine methyl ester are not soley mediated by inhibition of endothelial nitric oxide synthesis in the rat mesenteric artery J. Cardiovasc. Pharmacol. 33 1999 554-566